Literature DB >> 4202955

Further studies on the C3b inactivator or conglutinogen activating factor (KAF).

P J Lachmann, P Nicol, W P Aston.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4202955     DOI： 10.1016/0019-2791(73)90213-9

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  4 in total

1.  Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.

Authors:  J B Ziegler; C A Alper; R S Rosen; P J Lachmann; L Sherington
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

2.  The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.

Authors:  P J Lachmann; L Halbwachs
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

3.  Suramin stimulates B-lymphocyte proliferation in the mouse.

Authors:  T L Vischer
Journal:  Agents Actions       Date:  1976-07

4.  The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).

Authors:  J D Gitlin; F S Rosen; P J Lachmann
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.